These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 28761645)

  • 21. Tighter glycemic control is associated with ADL physical dependency losses in older patients using sulfonylureas or mitiglinides: Results from the DIMORA study.
    Abbatecola AM; Bo M; Armellini F; D'Amico F; Desideri G; Falaschi P; Greco A; Guerrini G; Lattanzio F; Volpe C; Paolisso G
    Metabolism; 2015 Nov; 64(11):1500-6. PubMed ID: 26318195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain.
    Miñambres I; Mediavilla JJ; Sarroca J; Pérez A
    BMC Endocr Disord; 2016 Feb; 16():10. PubMed ID: 26887662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Provider beliefs about diabetes treatment have little impact on glycemic control of their patients with diabetes.
    LeBlanc ES; Rosales AG; Kachroo S; Mukherjee J; Funk KL; Schneider JL; Nichols GA
    BMJ Open Diabetes Res Care; 2015; 3(1):e000062. PubMed ID: 25741443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing Unnecessary Costs of Drug-Induced Hypoglycemia in Older Adults with Type 2 Diabetes in the United States and Canada.
    Boulin M; Diaby V; Tannenbaum C
    PLoS One; 2016; 11(9):e0162951. PubMed ID: 27648831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Representativeness of patients and providers in the Canadian Primary Care Sentinel Surveillance Network: a cross-sectional study.
    Queenan JA; Williamson T; Khan S; Drummond N; Garies S; Morkem R; Birtwhistle R
    CMAJ Open; 2016; 4(1):E28-32. PubMed ID: 27331051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    Marso SP; Daniels GH; Brown-Frandsen K; Kristensen P; Mann JF; Nauck MA; Nissen SE; Pocock S; Poulter NR; Ravn LS; Steinberg WM; Stockner M; Zinman B; Bergenstal RM; Buse JB; ;
    N Engl J Med; 2016 Jul; 375(4):311-22. PubMed ID: 27295427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
    Zinman B; Wanner C; Lachin JM; Fitchett D; Bluhmki E; Hantel S; Mattheus M; Devins T; Johansen OE; Woerle HJ; Broedl UC; Inzucchi SE;
    N Engl J Med; 2015 Nov; 373(22):2117-28. PubMed ID: 26378978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.
    Fox CS; Golden SH; Anderson C; Bray GA; Burke LE; de Boer IH; Deedwania P; Eckel RH; Ershow AG; Fradkin J; Inzucchi SE; Kosiborod M; Nelson RG; Patel MJ; Pignone M; Quinn L; Schauer PR; Selvin E; Vafiadis DK; ; ;
    Diabetes Care; 2015 Sep; 38(9):1777-803. PubMed ID: 26246459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes.
    Hayward RA; Reaven PD; Wiitala WL; Bahn GD; Reda DJ; Ge L; McCarren M; Duckworth WC; Emanuele NV;
    N Engl J Med; 2015 Jun; 372(23):2197-206. PubMed ID: 26039600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences.
    Lin PJ; Kent DM; Winn A; Cohen JT; Neumann PJ
    Am J Manag Care; 2015 Jan; 21(1):e23-34. PubMed ID: 25880265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control.
    Lipska KJ; Ross JS; Miao Y; Shah ND; Lee SJ; Steinman MA
    JAMA Intern Med; 2015 Mar; 175(3):356-62. PubMed ID: 25581565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial.
    Gerstein HC; Miller ME; Ismail-Beigi F; Largay J; McDonald C; Lochnan HA; Booth GL;
    Lancet; 2014 Nov; 384(9958):1936-41. PubMed ID: 25088437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.
    von Elm E; Altman DG; Egger M; Pocock SJ; Gøtzsche PC; Vandenbroucke JP;
    Int J Surg; 2014 Dec; 12(12):1495-9. PubMed ID: 25046131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validating the 8 CPCSSN case definitions for chronic disease surveillance in a primary care database of electronic health records.
    Williamson T; Green ME; Birtwhistle R; Khan S; Garies S; Wong ST; Natarajan N; Manca D; Drummond N
    Ann Fam Med; 2014 Jul; 12(4):367-72. PubMed ID: 25024246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus.
    Vijan S; Sussman JB; Yudkin JS; Hayward RA
    JAMA Intern Med; 2014 Aug; 174(8):1227-34. PubMed ID: 24979148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential overtreatment and undertreatment of diabetes in different patient age groups in primary care after the introduction of performance measures.
    de Vries ST; Voorham J; Haaijer-Ruskamp FM; Denig P
    Diabetes Care; 2014; 37(5):1312-20. PubMed ID: 24595634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Standards of medical care in diabetes--2014.
    American Diabetes Association
    Diabetes Care; 2014 Jan; 37 Suppl 1():S14-80. PubMed ID: 24357209
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacologic management of type 2 diabetes.
    ; Harper W; Clement M; Goldenberg R; Hanna A; Main A; Retnakaran R; Sherifali D; Woo V; Yale JF
    Can J Diabetes; 2013 Apr; 37 Suppl 1():S61-8. PubMed ID: 24070965
    [No Abstract]   [Full Text] [Related]  

  • 39. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction.
    ; Cheng AY
    Can J Diabetes; 2013 Apr; 37 Suppl 1():S1-3. PubMed ID: 24070926
    [No Abstract]   [Full Text] [Related]  

  • 40. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010.
    Stark Casagrande S; Fradkin JE; Saydah SH; Rust KF; Cowie CC
    Diabetes Care; 2013 Aug; 36(8):2271-9. PubMed ID: 23418368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.